Status:
NOT_YET_RECRUITING
Prostate Adaptive Radiation Therapy
Lead Sponsor:
Royal North Shore Hospital
Collaborating Sponsors:
Northern Sydney and Central Coast Area Health Service
Conditions:
Prostatic Neoplasms
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Prostate ART is a two phase study looking at using adaptive radiotherapy to help reduce toxicity for prostate cancer patients. Adaptive radiotherapy is a new technology that provides the ability to a...
Detailed Description
Despite major technological advancements in the delivery of pelvic radiation therapy including the use of dynamic therapy, image guidance, integrated boosting and stereotactic techniques, toxicity fro...
Eligibility Criteria
Inclusion
- \- Age \> 18
- Biopsy proven prostate malignancy
- Definitive treatment is radiotherapy to the prostate alone
- ECOG performance status 0-2
- Ability to understand and the willingness to sign an informed consent
Exclusion
- Hip prosthesis
- Patient separation from prostate centre to skin edge \> 24cm, measured on diagnostic scan-
Key Trial Info
Start Date :
October 31 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2031
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06547398
Start Date
October 31 2024
End Date
October 31 2031
Last Update
October 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northern Sydney Cancer Centre, Royal North Shore Hospital
St Leonards, New South Wales, Australia, 2065